| Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study ME Weinblatt, EC Keystone, DE Furst, AF Kavanaugh, EK Chartash, ... Annals of the rheumatic diseases 65 (6), 753-759, 2006 | 313 | 2006 |
| Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. DJ Schendel, B Gansbacher, R Oberneder, M Kriegmair, A Hofstetter, ... Journal of immunology (Baltimore, Md.: 1950) 151 (8), 4209-4220, 1993 | 222 | 1993 |
| Uses and compositions for treatment of rheumatoid arthritis JR Medich, H Kupper, JD Kent, JL Perez, EH Sasso, O Segurado, ... US Patent App. 11/800,531, 2008 | 183 | 2008 |
| Rheumatoid arthritis joint progression in sustained remission is determined by disease activity levels preceding the period of radiographic assessment D Aletaha, J Funovits, FC Breedveld, J Sharp, O Segurado, JS Smolen Arthritis & Rheumatism 60 (5), 1242-1249, 2009 | 171 | 2009 |
| Most visits of most patients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count T Pincus, OG Segurado Annals of the Rheumatic Diseases 65 (6), 820-822, 2006 | 158 | 2006 |
| Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal … A Kivitz, S Cohen, JE Dowd, W Edwards, S Thakker, FR Wellborne, ... Clinical therapeutics 28 (10), 1619-1629, 2006 | 137 | 2006 |
| An index of patient reported outcomes (PRO-Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis. T Pincus, C Chung, OG Segurado, I Amara, GG Koch The Journal of Rheumatology 33 (11), 2146-2152, 2006 | 95 | 2006 |
| Uses and compositions for treatment of rheumatoid arthritis JR Medich, H Kupper, JL Perez, JD Kent, EH Sasso, O Segurado, ... US Patent App. 13/280,613, 2012 | 88 | 2012 |
| Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from … T Pincus, I Amara, OG Segurado, M Bergman, GG Koch The Journal of Rheumatology 35 (2), 201-205, 2008 | 86 | 2008 |
| Expression and function of a variant T cell receptor complex lacking CD3-gamma. P Pérez-Aciego, B Alarcon, A Arnaiz-Villena, C Terhorst, M Timon, ... The Journal of experimental medicine 174 (2), 319-326, 1991 | 76 | 1991 |
| Cost-effectiveness of sequential therapy with tumor necrosis factor antagonists in early rheumatoid arthritis A Davies, MA Cifaldi, OG Segurado, MH Weisman The Journal of Rheumatology 36 (1), 16-26, 2009 | 61 | 2009 |
| Comparison between HLA-DRB and DQ DNA sequences and classic serological markers as Type 11 (insulin-dependent) diabetes mellitus predictive risk markers in the Spanish population JL Vicario, J Martinez-Laso, A Corell, JM Martin-Villa, P Morales, G Lledo, ... Diabetologia 35, 475-481, 1992 | 56 | 1992 |
| HUMIRA® Pen: a novel autoinjection device for subcutaneous injection of the fully human monoclonal antibody adalimumab A Kivitz, OG Segurado Expert Review of Medical Devices 4 (2), 109-116, 2007 | 53 | 2007 |
| Clinical significance of serum and CSF findings in the Guillain-Barré syndrome and related disorders OG Segurado, H Krüger, HG Mertens Journal of neurology 233 (4), 202-208, 1986 | 52 | 1986 |
| Prospective clinical study of circulating tumor cells for colorectal cancer screening WS Tsai, A Nimgaonkar, O Segurado, Y Chang, B Hsieh, HJ Shao, JC Wu, ... J Clin Oncol 36 (4_suppl), 556, 2018 | 45 | 2018 |
| Vectra DA for the objective measurement of disease activity in patients with rheumatoid arthritis OG Segurado, EH Sasso Clin Exp Rheumatol 32 (5 Suppl 85), 29-34, 2014 | 38 | 2014 |
| Multibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concomitant … YC Lee, J Hackett, M Frits, CK Iannaccone, NA Shadick, ME Weinblatt, ... Rheumatology 55 (4), 640-648, 2016 | 36 | 2016 |
| Hemophilia A gene therapy: current and next-generation approaches SW Pipe, G Gonen-Yaacovi, OG Segurado Expert Opinion on Biological Therapy 22 (9), 1099-1115, 2022 | 34 | 2022 |
| Selective concentration of anti‐Purkinje cell antibody in the CSF of two patients with paraneoplastic cerebellar degeneration F Graus, OG Segurado, E Tolosa Acta neurologica scandinavica 78 (3), 210-213, 1988 | 31 | 1988 |
| Combined total deficiency of C7 and C4B with systemic lupus erythematosus (SLE) OG Segurado, A Arnáiz‐Villena, P Iglesias‐Casarrubios, J Martínez‐Laso, ... Clinical & Experimental Immunology 87 (3), 410-414, 1992 | 23 | 1992 |
theodore pincusprofessor of medicineVerified email at rush.edu
